Europe — EMA

Paclitaxel Accord

Paclitaxel, the active ingredient in Paclitaxel Accord, is a chemotherapy agent presented as a sterile injectable solution for intravenous use.

Paclitaxel

Request sourcing

Pack/s

What is Paclitaxel?

Paclitaxel, the active ingredient in Paclitaxel Accord, is a chemotherapy agent presented as a sterile injectable solution for intravenous use. It is employed in the treatment of various solid tumours and is administered under the supervision of oncology specialists.

GNH USA supplies Paclitaxel Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

What is Paclitaxel used for?

Paclitaxel Accord is used in oncology to interfere with the growth of cancer cells across several tumour types. - Breast cancer: helps the reducing tumour size and delaying progression. - Ovarian cancer: used as first line therapy or in combination with carb . - Non‑small cell NSCLC lung c ":[ ". - ". . - . - - . - - . - . - . - .\n"

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →